Liver fibrosis assessment: MR and US elastography

A Ozturk, MC Olson, AE Samir, SK Venkatesh - Abdominal Radiology, 2022 - Springer
Elastography has emerged as a preferred non-invasive imaging technique for the clinical
assessment of liver fibrosis. Elastography methods provide liver stiffness measurement …

Metformin actions on the liver: protection mechanisms emerging in hepatocytes and immune cells against NASH-related HCC

Y Zhang, H Wang, H Xiao - International Journal of Molecular Sciences, 2021 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is strongly linked to the global epidemic of obesity
and type 2 diabetes mellitus (T2DM). Notably, NAFLD can progress from the mildest form of …

[HTML][HTML] Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und …

E Roeb, A Canbay, H Bantel, J Bojunga… - Zeitschrift für …, 2022 - thieme-connect.com
Das Fortschreiten einer NASH ist assoziiert mit Leberzellstress, konsekutiver Entzündung
und Fibrose, mit potentieller Entwicklung einer Leberzirrhose, portaler Hypertension und der …

[HTML][HTML] Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German Society of Gastroenterology, digestive and …

F Tacke, A Canbay, H Bantel, J Bojunga… - Zeitschrift für …, 2022 - thieme-connect.com
Thieme E-Journals - Zeitschrift für Gastroenterologie / Full Text DE EN Home Products Journals
Books Book Series Service Library Service Help Contact Portal Zeitschrift für Gastroenterologie …

The utility and diagnostic accuracy of transient elastography in adults with morbid obesity: a prospective study

AH Ali, A Al Juboori, GF Petroski, AA Diaz-Arias… - Journal of Clinical …, 2022 - mdpi.com
Patients with morbid obesity are at high risk for nonalcoholic fatty liver disease (NAFLD)
complicated by liver fibrosis. The clinical utility of transient elastography (TE) by Fibroscan in …

Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated …

MA Tincopa, R Loomba - Seminars in Liver Disease, 2024 - thieme-connect.com
Risk of disease progression and clinical outcomes in metabolic dysfunction-associated
steatotic liver disease (MASLD) is associated with fibrosis stage and presence of “at-risk …

Ultrasound-based hepatic elastography in non-alcoholic fatty liver disease: focus on patients with type 2 diabetes

GD Cazac, CM Lăcătușu, C Mihai, ED Grigorescu… - Biomedicines, 2022 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease and is the
hepatic expression of metabolic syndrome. The development of non-invasive methods for …

The effect of genetic polymorphism in response to body weight reduction in Japanese patients with nonalcoholic fatty liver disease

Y Seko, K Yamaguchi, N Tochiki, K Yano, A Takahashi… - Genes, 2021 - mdpi.com
Background: weight loss as a result of lifestyle intervention is effective when treating non-
alcoholic fatty liver disease (NAFLD). We estimated the effects of PNPLA3 rs738409 and …

Comparison of visual transient elastography and shear wave elastography in evaluating liver fibrosis in patients with chronic liver disease

J Yang, J Li, G Ye, Y Luo - International Journal of General …, 2021 - Taylor & Francis
Purpose This study investigated the effectiveness and feasibility of shear wave elastography
((sound touch elastography) STE and (shear wave elastography) SWE) and visual transient …

[HTML][HTML] Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD–a prospective interventional study

A Vašura, E Machytka, O Urban, J Macháčková… - Annals of …, 2024 - Elsevier
ABSTRACT Introduction and Objectives: With increases in obesity and metabolic syndrome
because of lifestyle-related factors, the prevalence of non-alcoholic fatty liver disease …